CCL26 and Alzheimer disease: Although circulating eotaxin‐3 was not measured in the AD or EoE studies of this analysis, suppression of eotaxin‐3 messenger RNA was observed in the skin of AD patients and oesophageal biopsies of EoE patients treated with dupilumab in other studies.30, 31, 32